Author

Marty Schladen
Marty Schladen has been a reporter for decades, working in Indiana, Texas and other places before returning to his native Ohio to work at The Columbus Dispatch in 2017 and coming to the Ohio Capital Journal in 2020. He's won state and national journalism awards for investigations into utility regulation, public corruption, the environment, prescription drug spending and other matters.
LaRose says “no reasonable person” is talking about banning contraceptives. But his allies are
By: Marty Schladen - August 7, 2023
As they push to make it a lot harder for voters to amend the Ohio Constitution, Frank LaRose and Mike Gonidakis say that no “reasonable person” is considering a ban on contraceptives. That’s false — unless they believe U.S. Supreme Court Justice Clarence Thomas and a Republican member of the Ohio legislature aren’t reasonable people. […]
Affidavits: More pregnant minors who were raped denied Ohio abortions
By: Marty Schladen - September 23, 2022
At least two more minors made pregnant by sexual assault were forced to leave Ohio to avoid having their rapists’ babies, according to sworn affidavits filed by abortion providers. The affidavits were filed in Cincinnati as part of a lawsuit aimed at stopping enforcement of Ohio’s strict new abortion law, which it temporarily did last […]
Biden administration announces “comprehensive” plan to fix high drug prices
By: Marty Schladen - September 13, 2021
The U.S. Department of Health and Human Services last week issued its plan to address high drug prices as part of President Joe Biden’s push to take on anticompetitive practices across the economy. But while it addressed in detail abusive practices by drugmakers, it was a lot more superficial about the practices of much-larger corporations that serve […]
Big fight over drug pricing heads to the U.S. Supreme Court
By: Marty Schladen - October 5, 2020
A years-long fight over whether states have the authority to regulate important aspects of drug pricing will be argued before the U.S. Supreme Court Tuesday morning. At issue is whether prescription middlemen, known as “pharmacy benefit managers,” will have to bow to state authority over a huge swath of their business or if federal law […]
‘14,000 attempts.’ Balky technology, expiring benefits worry workers, state leaders
By: Marty Schladen - July 31, 2020
Congress is continuing to squabble over whether to extend a federal supplement to unemployment insurance and if they do, by how much. But as they argue over whether to continue the supplement at $600 a week or some fraction of that, out-of-work Americans are left to worry whether they can survive on state benefits that […]